Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UL
UL logo

UL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Unilever PLC (UL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
57.960
1 Day change
-0.97%
52 Week Range
74.970
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Unilever PLC is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks clear positive trading signals, has bearish technical indicators, and hedge funds are selling heavily. While analysts have recently reinstated buy ratings with attractive price targets, the overall sentiment is mixed, and there are no significant positive catalysts or strong financial data to support an immediate buy decision.

Technical Analysis

The technical indicators show a bearish trend with moving averages (SMA_200 > SMA_20 > SMA_5) and a neutral RSI of 37.969. The MACD histogram is positive but contracting, suggesting limited momentum. Key support is at 55.651, and resistance is at 58.588, indicating limited upside in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high option volume put-call ratio of 1.62 indicates bearish sentiment among traders, while the open interest put-call ratio of 0.82 is neutral to slightly bullish.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
3

Positive Catalysts

  • Analysts from BofA and DZ Bank have recently reinstated or upgraded the stock to Buy with attractive price targets, citing strong market positions in the U.S. and India. The company's transformation in the U.S. towards wellbeing and personal care is seen as a positive long-term driver.

Neutral/Negative Catalysts

  • Hedge funds are selling heavily, with a 443.74% increase in selling activity over the last quarter. Rising oil prices and input costs due to geopolitical tensions are expected to impact margins, as noted by analysts. Additionally, the stock has bearish technical indicators and lacks recent congress trading or influential figure support.

Financial Performance

No financial data was provided for the latest quarter, making it difficult to assess the company's recent growth trends. This lack of data adds uncertainty to the investment decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts' ratings are mixed. Recent upgrades to Buy from BofA and DZ Bank are offset by downgrades from Jefferies, Kepler Cheuvreux, and Deutsche Bank, citing valuation concerns and pricing challenges. Price targets range from 4,300 GBp to 5,900 GBp, reflecting mixed sentiment on the stock's potential.

Wall Street analysts forecast UL stock price to rise
3 Analyst Rating
Wall Street analysts forecast UL stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 58.530
sliders
Low
60.1
Averages
68.37
High
74
Current: 58.530
sliders
Low
60.1
Averages
68.37
High
74
BofA
NULL
to
Buy
initiated
£5,300
AI Analysis
2026-04-14
Reason
BofA
Price Target
£5,300
AI Analysis
2026-04-14
initiated
NULL
to
Buy
Reason
BofA reinstated coverage of Unilever with a Buy rating and 5,300 GBp price target. The firm's positive stance is based on the company's successful transformation in the U.S. towards more wellbeing and personal care, an "unrivalled market position" in the large and underpenetrated Indian market and a valuation that "now looks to us attractive," the analyst tells investors.
DZ Bank
Axel Herlinghaus
Hold
to
Buy
upgrade
2026-04-09
Reason
DZ Bank
Axel Herlinghaus
Price Target
2026-04-09
upgrade
Hold
to
Buy
Reason
DZ Bank analyst Axel Herlinghaus upgraded Unilever to Buy from Hold with a 5,250 GBp price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UL
Unlock Now

People Also Watch